Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Elizabeth Katherine Lee, M.D.

Concepts (118)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Cystadenocarcinoma, Serous320244781.340 Why?
Ovarian Neoplasms8202448761.130 Why?
Uterine Neoplasms2202414200.880 Why?
Carcinosarcoma120241050.880 Why?
Maytansine12019860.620 Why?
Antineoplastic Combined Chemotherapy Protocols72022117400.470 Why?
Genital Neoplasms, Female120195320.450 Why?
Doxorubicin1202022240.440 Why?
Immunoconjugates120199540.380 Why?
Antineoplastic Agents22023136370.310 Why?
Endometrial Neoplasms3202213650.300 Why?
Isoxazoles320242310.280 Why?
Deoxycytidine320248770.210 Why?
Pyrazines3202412010.210 Why?
Molecular Targeted Therapy2202428110.180 Why?
Drug Resistance, Neoplasm3202053050.180 Why?
Sodium-Phosphate Cotransporter Proteins, Type IIb12019100.170 Why?
Folate Receptor 112019400.160 Why?
DNA Polymerase II120191040.160 Why?
Neoplasms, Cystic, Mucinous, and Serous120201940.150 Why?
GPI-Linked Proteins120194680.140 Why?
Phenylurea Compounds120205290.140 Why?
Thromboplastin120192860.140 Why?
CA-125 Antigen120192810.140 Why?
Infusions, Intravenous1202022180.130 Why?
Camptothecin120195900.130 Why?
Drug Synergism1201917550.120 Why?
Quinolines120207640.120 Why?
Polyethylene Glycols1202011880.120 Why?
DNA Replication1202114180.120 Why?
Female1620243925810.110 Why?
Drug Design1201910480.110 Why?
Salvage Therapy1202012640.110 Why?
Hospitalists120172940.110 Why?
Tumor Suppressor Protein p532202029160.110 Why?
Cell Adhesion Molecules1201916000.100 Why?
Drug Administration Schedule1202048520.100 Why?
Membrane Proteins2201978560.100 Why?
Antigens, Neoplasm1201919940.090 Why?
Physicians, Primary Care120176230.090 Why?
Continuity of Patient Care1201710690.090 Why?
Fatigue1201715510.090 Why?
Disease-Free Survival1202068140.090 Why?
Toll-Like Receptor 4120135790.080 Why?
Enterocolitis, Necrotizing120133260.080 Why?
Survival Rate22020127200.080 Why?
Protein Kinase Inhibitors2202456650.080 Why?
Humans1720247614230.080 Why?
Stomach Neoplasms1201914590.080 Why?
Microcirculation1201312730.080 Why?
Dose-Response Relationship, Drug12020107660.080 Why?
High-Throughput Nucleotide Sequencing1202036390.070 Why?
Prognosis32024296200.070 Why?
Pancreatitis1201410960.070 Why?
Immunohistochemistry12020110730.070 Why?
Ligands2202232710.060 Why?
Attitude of Health Personnel1201738890.060 Why?
Randomized Controlled Trials as Topic12020102030.060 Why?
Communication1201738710.050 Why?
Signal Transduction22019234410.050 Why?
Disease Progression12020135020.050 Why?
Clinical Trials as Topic1201980000.050 Why?
Ribose12022630.050 Why?
Diphosphates12022840.050 Why?
Intestinal Mucosa1201330300.050 Why?
Mutation32021300450.050 Why?
Adenocarcinoma1201963390.050 Why?
Pancreatic Neoplasms1201953650.050 Why?
Retinoblastoma Binding Proteins120211010.050 Why?
Phthalazines120223830.040 Why?
Patient Readmission1201432690.040 Why?
DNA Mismatch Repair120224280.040 Why?
Platinum120202200.040 Why?
Omentum120191680.040 Why?
Aged520221692350.040 Why?
Middle Aged620202208260.030 Why?
Treatment Outcome22022646510.030 Why?
Carboplatin120197940.030 Why?
Oncogenes1202112220.030 Why?
Microtubule-Associated Proteins1202010760.030 Why?
Breast Neoplasms12022210120.030 Why?
Receptors, Estrogen1202222080.030 Why?
Neoplasm Recurrence, Local2202292770.030 Why?
Hospital Administration120173530.030 Why?
Phosphatidylinositol 3-Kinases1202228630.030 Why?
Nitrites120131590.030 Why?
Pennsylvania120146130.030 Why?
Receptor, erbB-21202225570.020 Why?
Nitrates120132630.020 Why?
Infant Formula120131930.020 Why?
Paclitaxel1201917320.020 Why?
Sulfones120134470.020 Why?
Nitric Oxide Synthase Type III120137040.020 Why?
Purines120136050.020 Why?
Milk, Human120134840.020 Why?
Neoplasms12017221640.020 Why?
Biopsy1202067660.020 Why?
Animals, Newborn1201326770.020 Why?
Microscopy, Confocal1201319700.020 Why?
Patient Care Team1201725230.020 Why?
Inpatients1201725480.020 Why?
Antibodies, Monoclonal1202291790.020 Why?
Analysis of Variance1201362310.010 Why?
Nitric Oxide1201321330.010 Why?
Predictive Value of Tests12020152620.010 Why?
Population Surveillance1201425970.010 Why?
Piperazines1201325230.010 Why?
Adolescent22020883130.010 Why?
Young Adult22020592070.010 Why?
Adult320202211480.010 Why?
Follow-Up Studies12020391170.010 Why?
Mice, Knockout12013144090.010 Why?
Aged, 80 and over12020589560.010 Why?
Time Factors12014399750.010 Why?
Risk Factors12014741670.000 Why?
Mice12013815090.000 Why?
Animals120131684410.000 Why?
Male120143607360.000 Why?
Lee's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (118)
Explore
_
Co-Authors (29)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.